LIPSOREX PLUS
LIPSOREX PLUS
Discontinued
DIN Number
02257432
Drug Class
Human
Market Date
Feb 15, 2005
Company
HC
sanofi consumer health inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02257432
AIG Number0450301001
Classification & Schedule
C
Drug Class
Human
S
Schedule
OTC
A
ATC Code
D04AB01 LIDOCAINE
Product Specifications
Dosage FormGel
Route of AdministrationTopical
AHFS Classification84:08.00
Health Canada Classification
ACTIVE INGREDIENTS (4)
BENZETHONIUM CHLORIDEActive
Strength: 0.28 %
Monograph: BENZETHONIUM CHLORIDE
LIDOCAINEActive
Strength: 2 %
Monograph: LIDOCAINE
MENTHOLActive
Strength: 0.97 %
Monograph: MENTHOL
THYMOLActive
Strength: 0.36 %
Monograph: THYMOL